Wolf Y G, Hill B B, Rubin G D, Fogarty T J, Zarins C K
Division of Vascular Surgery and the Department of Radiology, Stanford University Hospital, Stanford, CA 94305-5642, USA.
J Vasc Surg. 2000 Jul;32(1):108-15. doi: 10.1067/mva.2000.107754.
Untreated abdominal aortic aneurysms (AAAs) enlarge at a mean rate of 3.9 mm/y with great individual variability. We sought to determine the effect of endovascular repair on the rate of change in aneurysm size.
There were 110 patients who underwent endovascular AAA repair at Stanford University Medical Center and who were followed up for 1 to 30 months (mean, 10 months) with serial contrast-infused helical computed tomography (CT). Maximal aneurysm diameter was determined using two independent methods: (1) measured manually, from cross-sectional computed tomography (XSCT) angiograms and (2) calculated from quantitative three-dimensional computed tomography (3DCT) data as orthonormal diameter.
Maximal cross-sectional aneurysm diameter measured by hand (XSCT) and calculated as orthonormal values (3DCT) correlated closely (r = 0.915; P <.001). The XSCT-measured diameter was larger by 2.3 +/- 3. 75 mm (P <.001), and the 95% CI for SE of the bias was 1.85 to 2.75 mm. Preoperative aneurysm diameter (XSCT 59.1 +/- 8.4 mm; 3DCT 58.1 +/- 9.3 mm) did not differ significantly from the initial postoperative diameter. Considering all patients, XSCT diameter decreased at a rate of 0.34 +/- 0.69 mm/mo, and 3DCT diameter decreased at a rate of 0.28 +/- 0.79 mm/mo. Aneurysms in patients without endoleaks had a higher rate of decrease, an XSCT diameter by 0.50 +/- 0.74 mm/mo, and 3DCT diameter by 0.46 +/- 0.84 mm/mo. In these patients, mean absolute decrease in diameter at 6 months was 3. 4 +/- 4.5 mm (XSCT) and 3.3 +/- 5.9 mm (3DCT) and at 12 months, 5.9 +/- 5.7 mm (XSCT) and 5.4 +/- 5.7 mm (3DCT). Aneurysms in patients with persistent endoleaks did not change in mean XSCT diameter, and 3DCT diameter increased by 0.12 +/- 0.52 mm/mo (not significant). Aneurysm diameter remained within 4 mm of original size in 68% (3DCT) to 71% (XSCT) of patients. In one patient, aneurysm diameter increased (XSCT and 3DCT) more than 5 mm. Four patients who had a new onset endoleak had a much higher expansion rate than those with a chronic endoleak (P <.05).
The rate of decrease in aneurysm size (annualized 3.4-4.1 mm/y) after endovascular repair of AAA approximates the reported expansion rate in untreated aneurysms. However, individual aneurysm behavior is unpredictable, and the presence of an endoleak is unreliable in predicting changes in diameter. New onset endoleaks are associated with an enlargement rate greater than that of untreated aneurysms.
未经治疗的腹主动脉瘤(AAA)平均每年以3.9 mm的速度扩大,个体差异很大。我们试图确定血管内修复对动脉瘤大小变化率的影响。
110例患者在斯坦福大学医学中心接受了血管内AAA修复,并通过连续的增强螺旋计算机断层扫描(CT)进行了1至30个月(平均10个月)的随访。使用两种独立的方法确定动脉瘤的最大直径:(1)从横断面计算机断层扫描(XSCT)血管造影手动测量;(2)根据定量三维计算机断层扫描(3DCT)数据计算为正交直径。
手工测量(XSCT)和计算为正交值(3DCT)的最大横断面动脉瘤直径密切相关(r = 0.915;P <.001)。XSCT测量的直径大2.3±3.75 mm(P <.001),偏差标准误的95%置信区间为1.85至2.75 mm。术前动脉瘤直径(XSCT 59.1±8.4 mm;3DCT 58.1±9.3 mm)与术后初始直径无显著差异。考虑所有患者,XSCT直径以0.34±0.69 mm/月的速度减小,3DCT直径以0.28±0.79 mm/月的速度减小。无内漏患者的动脉瘤减小率更高,XSCT直径为0.50±0.74 mm/月,3DCT直径为0.46±0.84 mm/月。在这些患者中,6个月时直径的平均绝对减小量为3.4±4.5 mm(XSCT)和3.3±5.9 mm(3DCT),12个月时为5.9±5.7 mm(XSCT)和5.4±5.7 mm(3DCT)。有持续性内漏患者的动脉瘤平均XSCT直径没有变化,3DCT直径以0.12±0.52 mm/月的速度增加(无显著性)。68%(3DCT)至71%(XSCT)的患者动脉瘤直径保持在原始大小的4 mm范围内。1例患者的动脉瘤直径(XSCT和3DCT)增加超过5 mm。4例新发内漏患者的扩张率比慢性内漏患者高得多(P <.05)。
AAA血管内修复后动脉瘤大小的减小率(年化3.4 - 4.1 mm/年)接近未治疗动脉瘤的报道扩张率。然而,个体动脉瘤的行为是不可预测的,内漏的存在在预测直径变化方面并不可靠。新发内漏与比未治疗动脉瘤更大的扩大率相关。